FrancophonIA/ELRC3.0 huggingface dataset:
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton after EXP.
Croatian: Ne koristiti veterinarsko-medicinski proizvod poslije isteka roka valjanosti naznačenog na kutiji nakon EXP.
English: (**)Strain-specific pass levels
Croatian: (**)Specifični soj nivo
English: If used in other domestic and wild ruminant species that are considered at risk of infection, its use in these species should be undertaken with care and it is advisable to test the vaccine on a small number of animals prior to mass vaccination.
Croatian: Ako se primjenjuje drugim domaćim i divljim preživačima za koje se smatra da postoji opasnost od zaraze, tim vrstama treba primijeniti s oprezom, a preporučuje se i testiranje cjepiva na malom broju životinja, prije masovnog cijepljenja.
English: a) the administration of the product to animals will interfere with the implementation of a national programme for the diagnosis, control or eradication of animal diseases, or will cause difficulties in certifying the absence of contamination in live animals or in foodstuffs or other products obtained from treated animals.
Croatian: a) će primjena proizvoda na životinjama interferirati s provedbom nacionalnog programa otkrivanja, kontrole ili iskorjenjivanje bolesti životinja ili će prouzročiti poteškoće u certificiranju odsutnosti zaraze u živih životinja ili hrani ili drugim proizvodima dobivenim od tretiranih životinja. b) je bolest za koju je proizvod namijenjen da pruži imunost, u velikoj mjeri odsutna s odnosnog područja.
English: The type of strain(s) (two strains at most) included in the final product will be selected based on the epidemiological situation at the time of manufacturing and will be stated on the label.
Croatian: Vrsta sojeva (najviše dva različita soja) koji su uključeni u konačni proizvod bit će prilagođeni trenutnoj epidemiološkoj situaciji u vrijeme proizvodnje konačnog proizvoda i bit će navedeni na etiketi.
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Croatian: Detaljne informacije o ovom veterinarsko-medicinskom proizvodu su dostupne na web stranici Europske agencije za lijekove http://www.ema.europa.eu.
English: Any person intending to manufacture, import, possess, sell, supply and use of BTVPUR containing serotypes 1, 2, 4 and 8 must first consult the relevant Member State's competent authority on the current vaccination policies, as these activities may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation.
Croatian: Tko namjerava proizvoditi, uvesti, posjedovati, prodavati, opskrbljivati i primjenjivati BTVPUR koji sadrži serotipove 1, 2, 4 i 8 mora prvo konzultirati nadležno tijelo odnosne države članice u pogledu važećih odredbi o cijepljenju budući da se te aktivnosti mogu zabraniti u državi članici na cijelom ili dijelu njezina teritorija u skladu s nacionalnim zakonodavstvom.
English: Sheep and cattle.
Croatian: Ovce i goveda.
English: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Croatian: Bilo koji neupotrebljeni veterinarsko-medicinski proizvod ili otpadni materijali dobivenih primjenom tih veterinarsko-medicinskih proizvoda mora se odlagati u skladu s propisima o zbrinjavanju otpada.
English: The vaccine contains inactivated Bluetongue Virus with aluminium hydroxide and saponin adjuvants.
Croatian: Cjepivo sadrži inaktivirani virus bolesti plavog jezika s aluminijevim hidroksidom i saponinom kao adjuvansima.
English: For purification and bottling steps only: MERIAL Laboratory of Lyon Porte des Alpes Rue de l'Aviation,
Croatian: Samo za postupke pročišćavanja i punjenja bočica: MERIAL Laboratory of Lyon Porte des Alpes Rue de l'Aviation,
English: Administer one dose of 1 ml subcutaneously according to the following vaccination scheme:
Croatian: Injicirajte jednu dozu 1 ml cjepiva subkutano u skladu sa sljedećim rasporedom cijepljenja:
English: Can be used during pregnancy and lactation.
Croatian: Može se primijeniti tijekom graviditeta i dojenja.
English: (**) Antigen content (VP2 protein) by immuno-assay
Croatian: (**) Količina antigena (VP2 protein) dobivena imunološkim metodama
English: The safety and the efficacy of the vaccine have not been established in breeding males.
Croatian: Neškodljivost i djelotvornost cjepiva nisu ustanovljene na rasplodnim mužjacima.
English: Detailed information of this product is available on the website of the European Medicines Agency (http://www.ema.europa.eu).
Croatian: Detaljne informacije o ovom veterinarsko-medicinskom proizvodu su dostupne na web stranici Europske agencije za lijekove http://www.ema.europa.eu
English: Pharmacotherapeutic group: bluetongue virus vaccine, ATC vet code QI04AA02 (sheep) and QI02AA08 (cattle).
Croatian: Farmakoterapijska grupa: cjepivo protiv virusa bolesti plavog jezika, ATCvet kod QI04AA02 (ovce) i QI02AA08 (goveda).
English: Shelf life after first opening the immediate packaging: use immediately.
Croatian: Rok valjanosti poslije prvog otvaranja unutarnjeg pakovanja: upotrijebiti odmah.
English: 100 doses (100 ml)
Croatian: 100 doza (100 ml)
English: No other adverse reactions except those mentioned in section ‘Adverse Reactions' were observed.
Croatian: Nisu primijećeni nikakvi neželjeni učinci osim onih već spomenutih u odjeljku 'Nuspojave'.
English: *below the level of detection by the validated RT-PCR method at 3.68 log10 RNA copies/ml, indicating no infectious virus transmission.
Croatian: *vrijednosti ispod razine otkrivanja validiranom RT-PCR metodom na 3,68 log10 RNA kopija/ml, ukazuje na odsutnost zaraze virusom.
English: In this category of animals the vaccine should be used only according to the benefit/risk assessment by the responsible veterinarian and/or national Competent Authorities on the current vaccination policies against Bluetongue Virus (BTV).
Croatian: U toj kategoriji životinja cjepivo treba primijeniti samo po procjeni odnosa koristi/rizika od strane odgovornog veterinara i nadležnih tijela sukladno važećim odredbama o cijepljenju protiv virusa bolesti plavog jezika (BTV).
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Box of 1 bottle of 10 ml,
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU Kutija s 1 bočicom od 10 ml
English: Polypropylene bottle of 50 or 100 ml with butyl elastomer closure.
Croatian: Polipropilenska bočica od 50 ili 100 ml s čepom od butilnog elastomera.
English: Shake gently immediately before use.
Croatian: Neposredno prije upotrebe lagano protresite.
English: Silicon antifoam Phosphate buffer Glycine buffer Aluminium hydroxide Saponin
Croatian: 6.1 Popis pomoćnih tvari silikonsko sredstvo protiv pjenjenja fosfatni pufer glicinski pufer aluminijev hidroksid saponin
English: Each dose of 1 ml contains: Active substances *:
Croatian: Svaka doza od 1 ml sadrži: Djelatne tvari*:
English: 10 doses (10 ml) 50 doses (50 ml) 10 x 50 doses (10 x 50 ml) 100 doses (100 ml) 10 x 100 doses (10 x100 ml)
Croatian: 10 doza (10 ml) 50 doza (50 ml) 10 x 50 doza (10 x 50 ml) 100 doza (100 ml) 10 x 100 doza (10 x 100 ml)
English: It induces an active and specific immunity against Bluetongue Virus in the vaccinated animal.
Croatian: Ono inducira aktivnu i specifičnu imunost protiv virusa bolesti plavog jezika u cijepljenoj životinji.
English: Active substance*:
Croatian: Djelatne tvari*:
English: Type I glass bottle of 10 ml with butyl elastomer closure.
Croatian: Staklena bočica (tip I) od 10 ml sa čepom od butilnog elastomera.
English: BTVPUR suspension for injection for sheep and cattle
Croatian: BTVPUR suspenzija za injekciju za ovce i goveda
English: 6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Croatian: 6.6 Posebne mjere opreza za odlaganje neupotrebljenog veterinarsko-medicinskog proizvoda ili otpadnih materijala dobivenih primjenom tih proizvoda
English: For a monovalent vaccine containing an inactivated Bluetongue Virus serotypes 2 or 4, or for a bivalent vaccine containing both serotypes 2 and 4 together, one injection is sufficient.
Croatian: Kod primjene monovalentne vakcine koja sadrži inaktivirani virus bolesti plavog jezika serotip 2 ili 4, ili kod bivalentne vakcine koja sadrži oba serotipa 2 i 4 zajedno, jedna injekcija je dovoljna.
English: PACKAGE LEAFLET: BTVPUR suspension for injection for sheep and cattle
Croatian: UPUTA O VMP: BTVPUR suspenzija za injekciju za ovce i goveda
English: A confirmatory final potency test by seroneutralisation in rats is conducted when a batch is released
Croatian: Konačni potvrdni test jačine, sero neutralizacija u štakora provodi se pri puštanju serije
English: INDICATION(S)
Croatian: KARENCIJA(E)
English: Onset of immunity has been demonstrated 3 weeks (or 5 weeks in sheep for BTV2) after the primary vaccination course for BTV-1, BTV-2 (cattle), BTV-4 and BTV-8 serotypes.
Croatian: Početak imunosti: 3 tjedna (ili 5 tjedana u ovce kod BTV2) nakon prvog cijepljenja sa serotipovima BTV-1, BTV-2 (govedo), BTV-4 i BTV-8.
English: A confirmatory final potency test by seroneutralisation in rats is conducted when a batch is released.
Croatian: Konačni potvrdni test jačine, sero neutralizacija u štakora provodi se pri puštanju serije.
English: Avoid multiple vial broaching.
Croatian: Izbjegavajte višekratno otvaranje bočica.
English: A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Croatian: Stoga odluka o primjeni ovog cjepiva prije, odnosno poslije primjene bilo kojeg drugog veterinarsko-medicinskog proizvoda treba donositi od slučaja do slučaja.
English: Shelf life of monovalent or bivalent formulation with Bluetongue Virus serotypes 2 (100 ml, 50 ml and 10 ml bottles) and/or 4 (10 ml bottles): 18 months.
Croatian: Rok valjanosti monovalentne ili bivalentne formulacije s virusom bolesti plavog jezika serotip 2 (100 ml, 50 ml i 10 ml bočica) i/ ili 4 (10 ml bočica): 18 mjeseci.
English: Withdrawal period: zero days
Croatian: Karencija: nula dana
English: Shelf life of monovalent or bivalent formulation with Bluetongue Virus serotypes 1, 8 (100 ml, 50 ml and 10 ml bottles) and/or 4 (100 ml and 50 ml bottles): 2 years.
Croatian: Rok valjanosti monovalentne ili bivalentne formulacije s virusom bolesti plavog jezika serotip 1, 8 (100 ml, 50 ml i 10 ml bočica) i/ ili 4 (100 ml i 50 ml bočica): 2 godine.
English: • Revaccination Annual.
Croatian: • Docjepljivanje: Jednom godišnje.
English: B. CONDITIONS OR RESTRICTIONS OF REGARDING SUPPLY OR USE
Croatian: UVJETI ILI OGRANIČENJA U POGLEDU OPSKRBE I PRIMJENE
English: Manufacturer responsible for batch release: MERIAL
Croatian: Nositelj odobrenja za proizvodnju odgovoran za puštanje serije u promet: MERIAL
English: Subcutaneous use.
Croatian: Potkožna primjena.
English: Inactivated BTV1 ..................................................................................................... ≥ 1.9 log10 pixels Inactivated BTV2 ................................................................................................... ≥ 1.82 log10 pixels Inactivated BTV4 ................................................................................................... ≥ 1.86 log10 pixels Inactivated BTV8 ................................................................................................... ≥ 2.12 log10 pixels (*) maximum of two different inactivated bluetongue virus serotypes.
Croatian: Inaktivirani BTV1 .................................................................................................. ≥ 1.9 log10 piksela Inaktivirani BTV2 ................................................................................................ ≥ 1,82 log10 piksela Inaktivirani BTV4 ................................................................................................ ≥ 1.86 log10 piksela Inaktivirani BTV8 ................................................................................................ ≥ 2.12 log10 piksela (*) maksimum dva različita serotipa inaktiviranog virusa bolesti plavog jezika
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ BIOLOŠKI DJELATNE TVARI I PROIZVOĐAČ ODGOVORAN
English: Bottle of 10 and 50 ml
Croatian: Bočica od 10 ml i 50 ml
English: Disposal: read package leaflet
Croatian: Zbrinjavanje: pročitati uputu.
English: Box of 1 bottle of 10 doses (1 x 10 ml)
Croatian: Kutija s 1 bočicom od 10 doza (1 x 10 ml).
English: Bottle of 100 ml
Croatian: Bočica od 100 ml
English: 6.4 Special precautions for storage
Croatian: 6.4 Posebne mjere opreza pri čuvanju
English: 10 doses (10 ml) 50 doses (50 ml)
Croatian: 50 doza (50 ml).
English: Very rare and transient apathy can be observed after the administration of a double-dose of the vaccine.
Croatian: Nakon primjene dvostruke doze cjepiva vrlo rijetko je primijećena prolazna apatija.
English: 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Croatian: 4.10 Predoziranje (simptomi, hitni postupci, antidoti), ako je nužno Nakon primjene dvostruke doze cjepiva vrlo rijetko je primijećena prolazna apatija.
English: In very rare cases it has been observed a small local swelling at the injection site (at most 32 cm² in cattle and 24 cm² in sheep) which becomes residual 35 days later (≤ 1 cm In very rare cases a transient increase in body temperature, normally not exceeding an average of 1.1 ºC, may occur within 24 hours after vaccination.
Croatian: U vrlo rijetkim slučajevima može se pojaviti prolazno povišenje tjelesne temperature, obično ne prelazi više od 1,1 °C, 24 sata nakon cijepljenja.
English: Special precautions for use in animals: Not applicable.
Croatian: Posebna upozorenja za upotrebu kod životinja:
English: Box of 10 bottles of 100 ml
Croatian: Kutija s 10 bočica od 100 ml
English: Laboratory of Lyon Porte des Alpes Rue de l'Aviation,
Croatian: Laboratory od Lyon Porte des Alpes
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Croatian: - rijetke (više od 1 ali manje od 10 životinja na tretiranih 10.000 životinja).
English: Active immunisation of cattle to prevent viraemia* caused by bluetongue virus serotypes 1, 2, 4 and/or 8, and to reduce clinical signs caused by bluetongue virus serotypes 1, 4 and/or 8 (combination of maximum 2 serotypes).
Croatian: Aktivna imunizacija goveda za sprečavanje viremije* uzrokovane virusom bolesti plavog jezika serotipova 1, 2, 4 i/ili 8 te smanjenje kliničkih znakova uzrokovanih virusom bolesti plavog jezika serotipova 1, 4 i/ili 8 (kombinacija najviše dva različita soja).
English: Inactivated bluetongue virus ........................................ strain specific pass level (log10 pixels) ** (*) maximum of two different inactivated bluetongue virus serotypes
Croatian: Inaktivirani virus bolesti plavog jezika ………………≥ nivo specifičnog soja (log10 piksela)** (*) maksimum dva različita serotipa inaktiviranog virusa
English: Adjuvants: Al
Croatian: Al
English: Inactivated Bluetongue Virus ......................................... strain specific pass level (log10 pixels) ** * maximum of two different inactivated bluetongue virus serotypes
Croatian: Inaktivirani virus bolesti plavog jezika ………………≥ nivo specifičnog soja (log10 piksela)** * maksimum dva različita serotipa inaktiviranog virusa bolesti plavog jezika
English: Active immunisation of sheep to prevent viraemia* and to reduce clinical signs caused by Bluetongue Virus Serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).
Croatian: Aktivna imunizacija ovaca za sprečavanje viremije* i smanjenje kliničkih znakova uzrokovanih virusom bolesti plavog jezika serotipovi 1, 2, 4 i/ili 8 (kombinacija najviše dva različita soja).
English: Active immunisation of sheep to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).
Croatian: Aktivna imunizacija ovaca za sprečavanje viremije* i smanjenje kliničkih znakova uzrokovanih virusom bolesti plavog jezika serotipova 1, 2, 4 i/ili 8 (kombinacija najviše dva različita soja).
English: Box of 1 bottle of 50 ml,
Croatian: Kutija s 1 bočicom od 50 ml
English: 1.82 log10 pixels/mL
Croatian: 1,82 log10 piksela/mL
English: 1.86 log10 pixels/mL
Croatian: 1,86 log10 piksela/mL
English: Box of 10 bottles of 50 ml,
Croatian: Kutija s 10 bočica od 50 ml
English: 2.12 log10 pixels/mL
Croatian: 2,12 log10 piksela/mL
English: • Primary vaccination
Croatian: • Prvo cijepljenje
English: Box of 1 bottle of 100 ml,
Croatian: Kutija s 1 bočicom od 100 ml
English: 1.9 log10 pixels/mL
Croatian: 1,9 log10 piksela/mL
English: In cattle: - First injection: from 1 month of age in naive animals (or from 2.5 months of age in young animals born to immune cattle).
Croatian: U goveda - Prva injekcija: od 1 mjeseca starosti u prethodno necijepljenih životinja (ili od 2,5 mjeseca starosti u mladih životinja oteljenih od imunih krava).
English: In sheep: - First injection: from 1 month of age in naive animals (or from 2.5 months of age in young animals born to immune sheep).
Croatian: U ovaca - Prva injekcija: od 1 mjeseca starosti u prethodno necijepljenih životinja (ili od 2,5 mjeseca starosti u mladih životinja ojanjenih od imunih ovca).
English: In very rare cases it has been observed a small local swelling at the injection site (at most 32 cm² in cattle and 24 cm in sheep) which becomes residual 35 days later (≤ 1 cm In very rare cases a transient increase in body temperature, normally not exceeding an average of 1.1ºC, may occur within 24 hours after vaccination.
Croatian: 24 cm u ovaca) na mjestu uboda, koji se povlači za 35 dana (≤ 1 cm 2) nakon cijepljenja.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE
Croatian: OSNOVNI PODACI NA UNUTARNJEM PAKOVANJU
English: None
Croatian: I
English: Al3+ (as hydroxide) .................................................................................................................. 2.7 mg Saponin ................................................................................................................................... 30 HU** (**)Haemolytic units
Croatian: (kao hidroksid) ................................................................................................................... 2,7 mg Saponin ................................................................................................................................... 30 HU** Hemolitičke jedinice
English: In cattle st injection: from 1 month of age in naive animals (or from 2.5 months of age in young animals born to immune cattle).
Croatian: U goveda: - Prva injekcija: od 1 mjeseca starosti u prethodno necijepljenih životinja (ili od 2,5 mjeseca starosti u mladih životinja oteljenih od imunih krava).
English: MA (EU) Number
Croatian: EU broj odobrenja
English: (Invented) name
Croatian: (Zaštićeni) naziv lijeka
English: Route of Administration
Croatian: Način primjene
English: Packaging
Croatian: Pakiranje
English: Invented name Strength Pharmaceutical Form Route of Administration
Croatian: Broj EU odobrenja Zaštićeno ime Doza
English: The valid summary of product characteristics, labelling and package leaflet are the final versions achieved during the Coordination group procedure.
Croatian: Važeći sažetak opisa svojstava lijeka, označavanje i uputa o lijeku konačne su verzije dovršene tijekom postupka koordinacijske skupine.
English: The overall response rate was 14.1 %.
Croatian: Stopa ukupnog odgovora iznosila je 14,1%.
English: You might have any of these symptoms and/or conditions.
Croatian: Možete dobiti bilo koji od navedenih simptoma i/ili stanja.
English: Additional medicines:
Croatian: Dodatni lijekovi:
English: Thirst and increased water consumption
Croatian: Žeđ i povećan unos vode
English: Date of latest renewal: 20 September 2009
Croatian: Datum posljednje obnove odobrenja: 20. rujna 2009.
English: * Definition of frequency terms: Very common - ≥ 10%; Common - > 5% and < 10%.
Croatian: * Definicije pojmova učestalosti: vrlo često - ≥ 10%; često - > 5% i < 10%.
English: What ALIMTA is and what it is used for
Croatian: Što je ALIMTA i za što se koristi
English: Instructions for use, handling and disposal.
Croatian: Upute za uporabu, rukovanje i odlaganje.
English: Infection (sepsis) may be severe and could lead to death.
Croatian: Infekcija (sepsa) može biti vrlo teška i potencijalno smrtonosna.
English: Any diarrhoea requiring hospitalisation (irrespective of grade) or grade 3 or 4 diarrhoea.
Croatian: Svaki proljev koji zahtijeva hospitalizaciju (bez obzira na stupanj) ili proljev stupnja 3 ili 4
English: If you are pregnant, think you may be pregnant or are planning to have a baby, tell your doctor.
Croatian: Ako ste trudni, mislite da biste mogli biti trudni ili planirate imati dijete, obavijestite o tome svog liječnika.
English: Anaphylactic shock (severe allergic reaction)
Croatian: Anafilaktički šok (teška alergijska reakcija)
English: Other medicines and ALIMTA
Croatian: Drugi lijekovi i ALIMTA
English: The pH of the reconstituted solution is between 6.6 and 7.8.
Croatian: pripremljene otopine je između 6,6 i 7,8.
English: Animal studies have shown reproductive toxicity (see section 5.3).
Croatian: Istraživanja na životinjama pokazala su reproduktivnu toksičnost (vidjeti dio 5.3).
English: Based on the planned date of your infusion of ALIMTA and/or on the status of your kidney function, your doctor needs to advise you on which medicines you can take and when you can take them.
Croatian: Ovisno o planiranom datumu primjene infuzije lijeka ALIMTA i/ili Vašoj bubrežnoj funkciji, liječnik Vam mora reći koje lijekove možete uzimati i kada ih možete uzimati.
English: ALIMTA is a medicine used in the treatment of cancer.
Croatian: ALIMTA je lijek koji se koristi za liječenje raka.
English: Pharmacotherapeutic group: Folic acid analogues, ATC code: L01BA04
Croatian: Farmakoterapijska skupina: analozi folatne kiseline, ATK oznaka: L01BA04
English: Talk to your doctor or hospital pharmacist before receiving ALIMTA.
Croatian: Obratite se svom liječniku ili bolničkom ljekarniku prije nego primite lijek ALIMTA.
English: Your doctor will discuss with you the potential risk of taking ALIMTA during pregnancy.
Croatian: Liječnik će s Vama razgovarati o mogućem riziku primjene lijeka ALIMTA u trudnoći.
English: What you need to know before you use ALIMTA
Croatian: Što morate znati prije nego počnete primati lijek ALIMTA
English: Caution should be made when these drugs are combined with pemetrexed.
Croatian: Potreban je oprez kada se ti lijekovi kombiniraju s pemetreksedom.
English: You must tell your doctor as soon as possible when you start experiencing any of these side effects.
Croatian: Morate što prije obavijestiti svog liječnika ako primijetite bilo koju od ovih nuspojava.
English: From a microbiological point of view, the product should be used immediately.
Croatian: S mikrobiološkog stajališta lijek se mora odmah primijeniti.
English: In vitro studies indicate that pemetrexed is approximately 81 % bound to plasma proteins.
Croatian: Ispitivanja in vitro pokazuju da se oko 81% pemetrekseda veže za proteine u plazmi.
English: Between patient variability in clearance is moderate at 19.3 %.
Croatian: Varijabilnost klirensa između pojedinih bolesnika je umjerena i iznosi 19,3%.
English: CTC a Grade
Croatian: CTC a stupanj
English: Cisplatin is also given by infusion into one of your veins, and is given approximately 30 minutes after the infusion of ALIMTA has finished.
Croatian: Cisplatin se također primjenjuje infuzijom u jednu od vena i daje se približno 30 minuta nakon završetka infuzije lijeka ALIMTA.
English: Event**
Croatian: Događaj**